ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RCEL vs SGHT // OPERATING MARGIN

Avita Medical Inc. (NASDAQ) VS. Sight Sciences Inc. (NASDAQ) • 15-METRIC TALLY: RCEL 2 — SGHT 6
▲ OPERATING MARGIN LEADER: SGHT
operating-margins
-59.40%
operating-margins
-48.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RCEL VS. SGHT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RCEL SGHT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 82.10% 86.20% -4.10 SGHT /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.23% -5.67% -0.56 SGHT /fcf-yield <GO>
Operating Margin ACTIVE -59.40% -48.00% -11.40 SGHT /operating-margins <GO>
Net Profit Margin -60.00% -49.70% -10.30 SGHT /net-margins <GO>
Revenue Growth (YoY) 11.50% -3.10% +14.60 RCEL /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 2.16 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 SGHT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 71.6 62.6 +9.00 RCEL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $516.8M $527.2M -$10.4M SGHT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RCEL REV SGHT REV RCEL GROSS % SGHT GROSS % RCEL FCF SGHT FCF
FY 2025 $71.6M $77.4M 82.1% 86.2% -$32.2M -$29.9M
FY 2024 $64.3M $79.9M 85.8% 85.5% -$58.1M -$22.7M
FY 2023 $50.1M $81.1M — — -$38.0M -$47.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RCEL // BETA —
SGHT // BETA —